resveratrol has been researched along with Marfan Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Coskun, E; de Waard, V; Huveneers, S; Li, S; Mieremet, A; van der Stoel, M; van Krimpen, T | 1 |
| de Waard, V; Groenink, M; Mulder, BJM; van Andel, MM; Zwinderman, AH | 1 |
| de Vries, CJ; de Waard, V; Franken, R; Groenink, M; Gunst, Q; Hibender, S; Lutgens, E; Mulder, BJ; Pinto, YM; Schermer, EE; Ter Braake, A; van den Hoff, MJ; van der Made, I; van Roomen, C; Zwinderman, AH | 1 |
1 review(s) available for resveratrol and Marfan Syndrome
| Article | Year |
|---|---|
The Potential Beneficial Effects of Resveratrol on Cardiovascular Complications in Marfan Syndrome Patientsâ»Insights from Rodent-Based Animal Studies.
Topics: Animals; Antioxidants; Cardiotonic Agents; Heart; Humans; Marfan Syndrome; Resveratrol | 2019 |
2 other study(ies) available for resveratrol and Marfan Syndrome
| Article | Year |
|---|---|
Endothelial dysfunction in Marfan syndrome mice is restored by resveratrol.
Topics: Animals; Aorta; Aortic Aneurysm; Aortic Diseases; Fibrillin-1; Marfan Syndrome; Mice; Resveratrol | 2022 |
Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model.
Topics: Active Transport, Cell Nucleus; Animals; Aorta; Aortic Aneurysm; Apoptosis; Cells, Cultured; Cellular Senescence; Dilatation, Pathologic; Disease Models, Animal; Elastin; Female; Fibrillin-1; Genetic Predisposition to Disease; Human Umbilical Vein Endothelial Cells; Humans; Male; Marfan Syndrome; Mice, Inbred C57BL; Mice, Mutant Strains; MicroRNAs; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenotype; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Sirtuin 1; Stilbenes | 2016 |